Skip to main content
OpenTrials
Completed

NCT Number: NCT00954980

Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins

The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Varicose Veins Cardiovascular Diseases Embolism and Thrombosis Pathologic Processes Pathological Conditions, Signs and Symptoms Thrombosis Ulcer Vascular Diseases Venous Thrombosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Oklahoma Health Sciences Center campus at the OU Vascular Center

Oklahoma City, Oklahoma, 73104, United States

About this study

A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years. There are no deviations in usual clinical assessment and care of patients seeking varicose vein treatment. The purpose of this protocol is only to collect clinical and biomarker information related to this standard treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of varicose veins

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Frequency of obliteratin (total or partial) of injected varicosity.

    Time frame: assessment will be at 1, 12, and 26 weeks.

  2. Improvement in venous stasis symptoms.

    Time frame: assessment will be at 1, 12, and 26 weeks

  3. Change in quality of life.

    Time frame: assessment will be at 1, 12, and 26 weeks

  4. Associations between clinical outcomes and biomarkers.

    Time frame: assessment will be at 1, 12, and 26 weeks

Secondary outcomes

  1. Recurrence of varicosities.

    Time frame: assessment will be at 1, 12, and 26 weeks

  2. Adverse events reported following procedure.

    Time frame: assessment will be at 1, 12, and 26 weeks

Sponsors and collaborators

Lead sponsor

University of Oklahoma

Other

Registry information

Official study title

Evaluation of Clinical Characteristics of Endovenous Sclerotherapy of Varicose Veins

Important dates

Study start
2009
Primary completion
2012
Study completion
2016
First posted
Aug 7, 2009
Registry last updated
Nov 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.